Genetic Technologies
GENE
#10838
Rank
โ‚ฌ3.25 M
Marketcap
0,67ย โ‚ฌ
Share price
0.00%
Change (1 day)
-67.72%
Change (1 year)

Genetic Technologies (GENE) - Total debt

Total debt on the balance sheet as of June 2024 : โ‚ฌ0.51 Million

According to Genetic Technologies's latest financial reports the company's total debt is โ‚ฌ0.51 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Genetic Technologies - Total debt on balance sheet (from 2004 to 2024)

Total debt by year

Year Total debt Change
2024-06-30โ‚ฌ0.54 M68.85%
2023-06-30โ‚ฌ0.32 M-24.58%
2022-06-30โ‚ฌ0.42 M231.4%
2021-06-30โ‚ฌ0.12 M-56.12%
2020-06-30โ‚ฌ0.29 M
2019-06-30N/A
2015-06-30โ‚ฌ0.01 M-99%
2014-06-30โ‚ฌ1.72 M
2013-06-30N/A-100%
2012-06-30โ‚ฌ0.01 M-71.32%
2011-06-30โ‚ฌ0.05 M-80.55%
2010-06-30โ‚ฌ0.25 M20.89%
2009-06-30โ‚ฌ0.21 M17.36%
2008-06-30โ‚ฌ0.18 M-45.03%
2007-06-30โ‚ฌ0.33 M-66.55%
2006-06-30โ‚ฌ0.98 M-24.4%
2005-06-30โ‚ฌ1.3 M230.19%
2004-06-30โ‚ฌ0.39 M-2.85%
2003-06-30โ‚ฌ0.4 M
2002-06-30N/A-100%
2001-06-30โ‚ฌ0.07 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Thermo Fisher Scientific
TMO
โ‚ฌ37.89 B 7,368,225.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ5.62 B 1,093,514.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
โ‚ฌ16.22 B 3,155,437.04%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ6.35 B 1,235,995.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚ฌ2.58 M 402.93%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Neogen
NEOG
โ‚ฌ0.69 B 135,329.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
โ‚ฌ0.18 B 36,143.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚ฌ0.48 M-5.76%๐Ÿ‡บ๐Ÿ‡ธ USA